As of 2023, the antibacterial medicine sales in Canada were valued at 475 million Canadian Dollars. Forecast data indicates a declining trend from 2024, where sales are expected to start at 456 million, decreasing steadily to 379.6 million by 2028. Year-on-year percentage variations show consistent decreases of approximately 4.2% annually. This corresponds to a compound annual growth rate (CAGR) of around -4.3% over the five-year period from 2024 to 2028.

Future trends to watch for include:

Potential impacts of new healthcare policies aiming to reduce antibiotic resistance.
Innovations in medical treatments that could either reduce or shift the demand for traditional antibacterial medications.
Changes in population health management strategies, especially in response to emerging infectious diseases.
Developments in generic antibacterial drugs affecting market dynamics.